Immediate Impact
64 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Reactive Oxygen Species (ROS)-Mediated Antibacterial Oxidative Therapies: Available Methods to Generate ROS and a Novel Option Proposal
2024 Standout
Works of Lauren Maynard being referenced
BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)
2018
Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Lauren Maynard | 183 | 27 | 59 | 143 | 69 | 15 | 397 | |
| Medhat El-Sebaie | 139 | 86 | 101 | 21 | 18 | 371 | ||
| Stefano Monni | 89 | 1 | 42 | 73 | 21 | 18 | 341 | |
| L. Zeitz | 21 | 7 | 123 | 54 | 25 | 25 | 435 | |
| E Romo | 109 | 5 | 61 | 36 | 22 | 16 | 363 | |
| Mika Okazawa | 154 | 26 | 59 | 25 | 21 | 423 | ||
| Jake Patterson | 201 | 2 | 79 | 49 | 25 | 18 | 348 | |
| Carlos Roberto dos Santos | 140 | 2 | 60 | 102 | 7 | 19 | 358 | |
| Harrison Gallagher | 82 | 32 | 129 | 9 | 20 | 401 | ||
| Stuart M. Bergman | 264 | 60 | 46 | 37 | 20 | 403 | ||
| Jaime Furman | 161 | 3 | 186 | 77 | 40 | 16 | 424 |
All Works
Login with ORCID to disown or claim papers
Loading papers...